Chemoinformaics analysis of Pentadeca-2,4-dienal
| Molecular Weight | 222.372 | nRot | 11 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 0 |
| Exact Molecular Weight | 222.198 | nRing | 0 |
| Solubility: LogS | -6.186 | nHRing | 0 |
| Solubility: LogP | 6 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 43.1886 |
| nHD | 0 | BPOL | 26.9514 |
| QED | 0.528 |
| Synth | 2.855 |
| Natural Product Likeliness | 1.328 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.002 |
| HIA | 0.003 |
| CACO-2 | -4.399 |
| MDCK | 0.0000116 |
| BBB | 0.627 |
| PPB | 0.973619 |
| VDSS | 2.613 |
| FU | 0.0238518 |
| CYP1A2-inh | 0.776 |
| CYP1A2-sub | 0.416 |
| CYP2c19-inh | 0.499 |
| CYP2c19-sub | 0.856 |
| CYP2c9-inh | 0.664 |
| CYP2c9-sub | 0.882 |
| CYP2d6-inh | 0.04 |
| CYP2d6-sub | 0.047 |
| CYP3a4-inh | 0.142 |
| CYP3a4-sub | 0.184 |
| CL | 9.429 |
| T12 | 0.126 |
| hERG | 0.021 |
| Ames | 0.004 |
| ROA | 0.026 |
| SkinSen | 0.746 |
| Carcinogencity | 0.05 |
| EI | 0.98 |
| Respiratory | 0.193 |
| NR-Aromatase | 0.003 |
| Antiviral | Yes |
| Prediction | 0.796475 |